HF
RPRX icon

HRT Financial’s Royalty Pharma RPRX Stock Holding History

HRT Financial’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.73M Buy
202,847
+126,106
+164% +$5.52M 0.02% 629
2025
Q4 		$2.96M Sell
76,741
-867,910
-92% -$33.1M 0.01% 1047
2025
Q3 		$33.3M Buy
944,651
+712,731
+307% +$25.8M 0.12% 101
2025
Q2 		$8.36M Buy
231,920
+115,846
+100% +$3.84M 0.04% 365
2025
Q1 		$3.61M Buy
116,074
+70,349
+154% +$2.23M 0.02% 567
2024
Q4 		$1.17M Buy
+45,725
New +$1.21M 0.01% 999
2024
Q2 		– Sell
-130,188
Closed -$3.95M – 2965
2024
Q1 		$3.95M Buy
+130,188
New +$3.84M 0.02% 335
2023
Q4 		– Sell
-103,916
Closed -$2.82M – 2959
2023
Q3 		$2.82M Sell
103,916
-258,823
-71% -$7.69M 0.03% 475
2023
Q2 		$11.2M Buy
+362,739
New +$12.3M 0.1% 129
2023
Q1 		– Sell
-119,689
Closed -$4.73M – 3097
2022
Q4 		$4.73M Buy
+119,689
New +$5M 0.07% 283
2022
Q3 		– Sell
-60,283
Closed -$2.53M – 3398
2022
Q2 		$2.53M Buy
+60,283
New +$2.47M 0.03% 480
2021
Q3 		– Sell
-310,887
Closed -$12.7M – 3691
2021
Q2 		$12.7M Buy
+310,887
New +$13.2M 0.12% 154
2020
Q3 		– Sell
-70,234
Closed -$3.41M – 2277
2020
Q2 		$3.41M Buy
+70,234
New +$3.48M 0.1% 201

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HRT Financial's RPRX Position: Q1 2026 in Review

HRT Financial increased its Royalty Pharma (RPRX) stake by 164% in Q1 2026, buying an estimated $5.52M and bringing the position to 202,847 shares worth $9.73M. The position accounts for 0.02% of the portfolio, ranked #629.

HRT Financial first reported a position in RPRX in Q2 2020 and has held it in 13 quarters since. The position peaked at $33.3M in Q3 2025. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • HRT Financial held 202,847 shares of Royalty Pharma worth $9.73M as of Q1 2026.
  • HRT Financial bought 126,106 Royalty Pharma shares in Q1 2026, an estimated $5.52M.
  • Royalty Pharma made up 0.02% of HRT Financial's portfolio in Q1 2026, its #629 holding.
  • HRT Financial first reported a position in Royalty Pharma in Q2 2020 and has held it in 13 quarters since.
  • HRT Financial's Royalty Pharma position peaked at $33.3M in Q3 2025.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.